Literature DB >> 19880813

Why do tumors become resistant to antiangiogenesis drugs?

Charlie Schmidt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19880813     DOI： 10.1093/jnci/djp425

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  2 in total

1.  Beyond anti-VEGF: dual-targeting antiangiogenic and antiproliferative therapy.

Authors:  Chun-Te Chen; Mien-Chie Hung
Journal:  Am J Transl Res       Date:  2013-05-24       Impact factor: 4.060

2.  A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patients.

Authors:  Paolo Fardin; Annalisa Barla; Sofia Mosci; Lorenzo Rosasco; Alessandro Verri; Rogier Versteeg; Huib N Caron; Jan J Molenaar; Ingrid Ora; Alessandra Eva; Maura Puppo; Luigi Varesio
Journal:  Mol Cancer       Date:  2010-07-12       Impact factor: 27.401
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.